Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies into how antifungal drugs impact the spectrum of mutations observed during adaption primarily focused on increasing FLC concentrations or on short-term evolution experiments in a single concentration of FLC (Cowen et al. 2000; Anderson et al. 2003; Mount et al. 2018; Rybak et al. 2020; Burrack et al. 2022).”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Mount et al. 2018
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For heterozygous diploids such as C. albicans, loss of heterozygosity (LOH) is another frequent mechanism of resistance (reviewed in Refs. 52 and 53).”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [52]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The inter-isolate heterogeneity is likely due to genetic differences that contribute to several other clinically relevant phenotypes, including biofilm formation, filamentous growth responses and sensitivity to temperature52,60,79,80.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [52]
Experimental — accuracy not yet measuredIn the citing paper
“Chr3 aneuploidy was previously identified to confer an increase in FLC tolerance, due at least in part to an extra copy of the urea transporter NPR2 (Mount et al. 2018).”
From Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole (2022) · cites this paper as Mount et al. 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Self-citationGlobal Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,095
Self-citationA global genetic interaction network maps a wiring diagram of cellular function
Costanzo, M., VanderSluis, B., Koch, E. N., Baryshnikova, A., Pons, C., Tan, G., Wang, W., Usaj, M., Hanchard, J., Lee, S. D., et al. (2016) · Science · doi:10.1126/science.aaf1420 · Cited by 1,240
Self-citationEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Candida albicans morphogenesis and host defence: discriminating invasion from colonization
Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P., & Netea, M. G. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2711 · Cited by 888
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Self-citationHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Self-citationNoble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationDrug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs
Todd, R. T., & Selmecki, A. (2020) · eLife · doi:10.7554/elife.58349 · Cited by 138
Self-citationGenome plasticity in Candida albicans is driven by long repeat sequences
Todd, R. T., Wikoff, T. D., Forche, A., & Selmecki, A. (2019) · eLife · doi:10.7554/elife.45954 · Cited by 118
“Isolate AMS3053 was obtained on 20 mg/ml Miconazole agar plates as previously described (Mount et al., 2018).”
MethodSelf-citationA CRISPR Interference Platform for Efficient Genetic Repression in Candida albicans
Wensing, L. F., Sharma, J., Uthayakumar, D., Proteau, Y., Chavez, A., & Shapiro, R. S. (2019) · mSphere · doi:10.1128/msphere.00002-19 · Cited by 76
A Double-Edged Sword: Aneuploidy is a Prevalent Strategy in Fungal Adaptation
Tsai, H.-J., & Nelliat, A. (2019) · Genes · doi:10.3390/genes10100787 · Cited by 60
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53
“…antifungal drugs impact the spectrum of mutations observed during adaption primarily focused on increasing FLC concentrations or on short-term evolution experiments in a single concentration of FLC (Cowen et al. 2000; Anderson et al. 2003; Mount et al. 2018; Rybak et al. 2020; Burrack et al. 2022).”
Self-citationGerstein, A. C., & Berman, J. (2020) · mSphere · doi:10.1128/msphere.00480-20 · Cited by 44
“In many other cases, more than one gene may contribute to the phenotype (22, 27, 48, 68, 69).”
Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
The Role of Structural Variation in Adaptation and Evolution of Yeast and Other Fungi
Gorkovskiy, A., & Verstrepen, K. J. (2021) · Genes · doi:10.3390/genes12050699 · Cited by 47
Kukurudz, R. J., Chapel, M., Wonitowy, Q., Adamu Bukari, A.-R., Sidney, B., Sierhuis, R., & Gerstein, A. C. (2022) · G3 · doi:10.1093/g3journal/jkac156 · Cited by 35
“Chromosome 3 aneuploidy was previously identified to confer an increase in FLC tolerance, due at least in part to an extra copy of the urea transporter NPR2 (Mount et al. 2018).”
BackgroundGervais, N. C., Bella, A. A. L., Wensing, L. F., Sharma, J., Acquaviva, V., Best, M. A., López, R. O. C., Fogal, M., Uthayakumar, D., Chavez, A., et al. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac301 · Cited by 31
“…(Lohse et al. 2016; Hossain et al. 2020), pathogenesis (Noble et al. 2010; Nobile et al. 2012; Ryan et al. 2012; O‘Meara et al. 2015; Lee et al. 2016; Hossain et al. 2020), and mechanisms of drug and stress tolerance (Motaung et al. 2017; Mount et al. 2018; Caplan et al. 2018; Fu et al. 2021).”
BackgroundZhou, X., Hilk, A. L., Solis, N. V., Scott, N. E., Beach, A., Soisangwan, N., Billings, C. L., Burrack, L. S., Filler, S. G., & Selmecki, A. M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01795-7 · Cited by 23
“27,28,34–36).”
Self-citationEffect of Cold Atmospheric Plasma Jet Associated to Polyene Antifungals on Candida albicans Biofilms
Leite, L. D. P., de Oliveira, M. A. C., Vegian, M. R. D. C., Sampaio, A. D. G., Nishime, T. M. C., Kostov, K. G., & Koga‐Ito, C. Y. (2021) · Molecules · doi:10.3390/molecules26195815 · Cited by 23
Identification and Elimination of Antifungal Tolerance in Candida auris
Rasouli Koohi, S., Shankarnarayan, S. A., Galon, C. M., & Charlebois, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11030898 · Cited by 20
Gregor, J. B., Gutierrez-Schultz, V. A., Hoda, S., Baker, K. M., Saha, D., Burghaze, M. G., Vazquez, C., Burgei, K. E., & Briggs, S. D. (2023) · mSphere · doi:10.1128/msphere.00311-23 · Cited by 25
“In addition, Candida albicans , Neurospora crassa, and Fusarium verticillioides fungal species deleted for ERG5 show susceptibility to azoles, which has led to a hypothesis that Erg5 may serve as an azole buffer for Erg11 in these fungal species (34, 35).”
BackgroundBrilacidin, a novel antifungal agent against Cryptococcus neoformans
Diehl, C., Pinzan, C. F., de Castro, P. A., Delbaje, E., García-Carnero, L. C., Sánchez‐León, E., Bhalla, K., Kronstad, J. W., Kim, D.-G., Doering, T. L., et al. (2024) · mBio · doi:10.1128/mbio.01031-24 · Cited by 19
“Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 attenuate azole toxicity in both S. cerevisiae and Candida albicans ; they fail to synthe size ergosterol and exhibit increased resistance to azole antifungal drugs (49, 50).”
BackgroundSelf-citationFunctional divergence of a global regulatory complex governing fungal filamentation
Polvi, E. J., Veri, A. O., Liu, Z., Hossain, S., Hyde, S., Kim, S. H., Tebbji, F., Sellam, A., Todd, R. T., Xie, J. L., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007901 · Cited by 16
Self-citationKsiezopolska, E., Schikora-Tamarit, M. À., Carlos Nunez-Rodriguez, J., & Gabaldón, T. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1416509 · Cited by 15
Taylor, M. B., Skophammer, R. G., Warwick, A. R., Geck, R. C., Boyer, J. M., Students, Y., Walson, M., Large, C. R. L., Hickey, A. S.-M., Rowley, P. A., et al. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac246 · Cited by 15
Halder, V., McDonnell, B., Uthayakumar, D., Usher, J., & Shapiro, R. S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa055 · Cited by 15
Späth, G. F., & Bussotti, G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1237 · Cited by 13
“We analyzed nineteen samples, including (i) four clinical isolates (P75063, P75016, 199 P78042, SC5314), (ii) seven strains selected in vitro against the anti-fungal drug fluconazole 200 (FLC) (AMS4104, AMS4105, AMS4106, AMS4107, AMS4397, AMS4444, AMS4702), (iii) 201 four isogenic colonies adapted to the drug miconazo…”
BackgroundScanlan, J. L., Mitchell, A., Marcroft, S. J., Forsyth, L., Idnurm, A., & de Wouw, A. P. V. (2023) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2023.103814 · Cited by 15
Polyphyllin I Effects Candida albicans via Inhibition of Virulence Factors
Sun, A.-M., Wang, Y.-X., Hu, G.-X., Li, L., & Wang, R.-R. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/5645500 · Cited by 14
“albicans are highly limited owing to problems of insufcient drug efcacy, severe toxicity, adverse side efects, high cost, and the emergence of drug-resistant strains to clinically available antifungal drugs [10, 11].”
BackgroundA data library of Candida albicans functional genomic screens
Gervais, N. C., Halder, V., & Shapiro, R. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab060 · Cited by 10
The Use of Whole Genome and Next-Generation Sequencing in the Diagnosis of Invasive Fungal Disease
El-Kamand, S., Papanicolaou, A., & Morton, C. O. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00363-5 · Cited by 9
Identifying Candida albicans Gene Networks Involved in Pathogenicity
Thomas, G., Bain, J. M., Budge, S., Brown, A. J. P., & Ames, R. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00375 · Cited by 6
“, 2017) and these mutants abrogate azole resistance (Mount et al., 2018).”
BackgroundToxicology of Antifungal and Antiviral Drugs
Bano, S., Ahmedi, S., Manzoor, N., & Dey, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_24 · Cited by 6
Shapiro, R. S., & Gerstein, A. C. (2023) · mBio · doi:10.1128/mbio.01073-23 · Cited by 4
Recurrent copy number variations in the human fungal pathogen Candida parapsilosis
Selmecki, A. M. (2023) · mBio · doi:10.1128/mbio.00713-23 · Cited by 4
“Additionally, some CNVs are rapidly expanda ble in the presence of selection and reversible in the absence of selection, including some high copy number CNVs that arise during adaptation to azole drugs (26–28).”
BackgroundSelf-citationRovetta, S. D. M., Miranda, F., da Silva, D. M., Marcondes, M. S., Pessoa, R. S., & Koga‐Ito, C. Y. (2025) · ACS Omega · doi:10.1021/acsomega.5c06368 · Cited by 5
Taylor, M. B., Skophammer, R. G., Warwick, A. R., Boyer, J. M., Students, Y., Walson, M., Large, C. R. L., Hickey, A. S.-M., Rowley, P. A., & Dunham, M. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.02.442375 · Cited by 3
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
Targeting Casein Kinases in the Fungal Pathogen Candida albicans
Hyde, S. (2020) · TSpace (University of Toronto)
Metadata
- Authors
- Mount, H. O., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., Boone, C., Robbins, N., Selmecki, A., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Creighton University (US)
- Corresponding author
- Cowen, Leah E.
- ORCID
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-04-27
- Volume
- 14
- Issue
- 4
- Pages
- e1007319
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC5922528
- OpenAlex
- W2801204339
- Cited by
- 34
- References
- 80
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 7 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 6
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (1R01AI127375-01, R01HG005853)
- Canadian Institutes of Health Research (FDN-143264, MOP-86452, MOP-119520, FDN-154288)
- Natural Sciences and Engineering Research Council of Canada (06261, 462167)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- azole resistance, Candida albicans, ERG3, ergosterol biosynthesis, calcineurin, retrograde transport, chromosome amplification, antifungal resistance, invasive fungal infections
- MeSH terms
- Whole Genome Sequencing, Antifungal Agents, Azoles, Candida albicans, Humans, Microbial Sensitivity Tests, Mutation, Mycoses, Oxidoreductases, Saccharomyces cerevisiae, GTPase-Activating Proteins, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Vesicular Transport Proteins, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.